← Back to Cardlytics, Inc.
Stoqly stoqly.net Company report · October 28, 2026

Cardlytics, Inc.

CDLX Nasdaq· Services-Computer Programming, Data Processing, Etc.

Last close · Oct 27, 2026

$1.68

KIRA · Stoqly’s AI analyst, in plain words

  • Cardlytics, Inc. had $233M of revenue in fiscal 2025, down 16.2% on the year before. Over five years, revenue changed +4.5% a year on average.
  • Its operating margin was −43.6%, up 26.6 pts: of every 100 in sales, about −44 is left after running the business.
  • Cardlytics, Inc. lost $103M in fiscal 2025.
  • Free cash flow was $8.8M in fiscal 2025, 3.8% of revenue.
  • Cardlytics, Inc. owes $160M more than it holds in cash.

Market cap

$9.7M

P/E

—

Revenue

$233M

Net income

−$103M

Free cash flow

$8.8M

Operating margin

−43.6%

Cardlytics, Inc. in 30 seconds · fiscal 2025

Weak

Are sales growing?

−16.2%

No. Sales fell 16.2% last year.

Weak

Does it make a profit?

−44.4%

No. It lost money last year.

So-so

Does profit turn into cash?

3.8%

Partly. 3.8% of sales ends up as free cash.

So-so

How healthy are the accounts?

5 / 8

Mixed. It passes 5 of 8 health tests.

For information

How is the share priced?

—

No P/E: it made no profit over the last four quarters.

What Cardlytics, Inc. does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K · Mar 4, 2026
Legal name
Cardlytics, Inc.
CIK
0001666071
stoqly.net · CDLX · Generated October 28, 2026 Not investment advice · Page 1 of 3
Stoqly stoqly.net Company report · October 28, 2026

Cardlytics, Inc. · CDLX

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $267M $299M $309M $278M $233M
Revenue growth 42.9% 11.8% 3.6% −10.0% −16.2%
Net interest income −$12.6M −$2.6M −$2.3M — —
Operating margin −45.9% −153.3% −43.9% −70.2% −43.6%
Net income −$129M −$465M −$135M −$189M −$103M
Net margin −48.1% −155.8% −43.6% −68.0% −44.4%
Diluted EPS −$3.99 −$13.92 −$3.69 −$3.91 −$1.95
Cash
Cash from operations −$38.5M −$53.9M −$0.2M −$8.8M $9.3M
Capital expenditure $3.1M $1.2M $0.7M $1.6M $0.5M
Free cash flow −$41.6M −$55.1M −$0.9M −$10.4M $8.8M
FCF margin −15.6% −18.4% −0.3% −3.7% 3.8%
Share buybacks $0.0M $40.0M $0.0M $0.0M —
Share count change 18.3% 3.8% 9.2% 32.5% 9.8%
Debt and strength
Cash and short-term investments $233M $122M $91.8M $65.6M $48.7M
Debt incl. finance leases $184M $226M $258M $259M $209M
Shareholders' equity $691M $212M $135M $70.0M −$6.5M
Current ratio 1.1x 1.0x 1.3x 1.2x 1.8x
Interest coverage −9.7x −114.4x −21.9x −22.0x —
Returns and quality
Return on capital −15.1% −114.5% −35.7% −58.5% −52.3%
Return on equity −30.3% −103.1% −77.8% −184.9% −326.0%
Piotroski F-score 3 2 4 2 5
Altman Z'' −0.6 −8.6 −7.0 −13.4 −17.1

Insiders bought, 12 months

$0.1M

1 insider

Insiders sold, 12 months

$0.5M

3 insiders

Of sales under plans

0%

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net · CDLX · Generated October 28, 2026 Not investment advice · Page 2 of 3
Stoqly stoqly.net Company report · October 28, 2026

Cardlytics, Inc. · CDLX

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $1.68 a share, the company is worth $9.7M.

Source: SEC EDGAR XBRL filings (CIK 0001666071). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.